Evolus EOLS
NASDAQ EOLS
$7.11 +0.30 (+4.33%)
As of: Nov 11, 2026 · 10:42 AM EST

Evolus (EOLS) Non Operating Interest Expenses (2018 - 2026)

Updated

Evolus' Non Operating Interest Expenses came in at $4.25 million for Q3 2026, up 3.7% from $4.09 million a year earlier and up 1.8% from the prior quarter.

Analysis

Evolus (EOLS) Non Operating Interest Expenses (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2026, Evolus reported Non Operating Interest Expenses of $16.37 million, down 19.3% year-over-year; for FY2025, it was $19.69 million, up 5.1% from FY2024.

  • Non Operating Interest Expenses has increased in each of the last four years, with a four-year compound annual growth rate of 93.8% (FY2021 to FY2025).
  • Going back by year, Non Operating Interest Expenses was $18.74 million in FY2024 (+35.4%), $13.83 million in FY2023 (+52.1%), $9.1 million in FY2022 (+551.6%) and $1.4 million in FY2021.
  • The Q3 2026 figure represents the highest quarterly Non Operating Interest Expenses since Q2 2025.
  • Year-over-year, Non Operating Interest Expenses increased in three of the last eight quarters, with an average decline of 2.0%.
  • The fastest year-over-year change in Non Operating Interest Expenses over five years came in Q3 2022 (growth of 653.4%), and the weakest in Q2 2026 (a decline of 42.1%).
  • Business Quant data shows EOLS's Non Operating Interest Expenses at $4.17 million (Q2 2026), $3.98 million (Q1 2026) and $3.98 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Operating Interest Expenses (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 217.00 Mn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -477.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 653.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 269.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Evolus 450.43 Mn 259.94 Mn 50.69 Mn 4.25 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.25 Mn
Jun 30, 2026 4.17 Mn
Mar 31, 2026 3.98 Mn
Dec 31, 2025 3.98 Mn
Sep 30, 2025 4.09 Mn
Jun 30, 2025 7.21 Mn
Mar 31, 2025 4.42 Mn
Dec 31, 2024 4.57 Mn
Sep 30, 2024 4.76 Mn
Jun 30, 2024 4.70 Mn
Mar 31, 2024 4.70 Mn
Dec 31, 2023 4.08 Mn
Sep 30, 2023 3.79 Mn
Jun 30, 2023 3.18 Mn
Mar 31, 2023 2.79 Mn
Dec 31, 2022 2.63 Mn
Sep 30, 2022 2.34 Mn
Jun 30, 2022 2.08 Mn
Mar 31, 2022 2.05 Mn
Dec 31, 2021 140,000.00
API Access

Evolus Non Operating Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=EOLS&period=max&api_key=YOUR_API_KEY